CLINICAL_TRIALS research · 2023-01-30

Clinical Trial Update: Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS) [NA]

A completed clinical trial evaluating active monitoring as a treatment option for ductal carcinoma in situ (DCIS). Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Duke University | Conditions: Ductal Carcinoma in Situ | NA | Status: COMPLETED | Results posted: 2023-01-30